Austar Lifesciences Limited
AULSF
$0.07
$0.0651,300.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 709.10K | 712.50K | 405.80K | 409.30K | -5.09M |
| Total Depreciation and Amortization | 1.74M | 1.75M | 1.55M | 1.56M | 1.59M |
| Total Amortization of Deferred Charges | 236.80K | 238.00K | 189.90K | 191.50K | 223.10K |
| Total Other Non-Cash Items | 1.16M | 1.16M | -797.50K | -804.40K | 12.10M |
| Change in Net Operating Assets | 1.67M | 1.68M | -- | -- | -8.66M |
| Cash from Operations | 5.51M | 5.54M | 1.35M | 1.36M | 151.00K |
| Capital Expenditure | -1.04M | -1.04M | -385.20K | -388.50K | -2.40M |
| Sale of Property, Plant, and Equipment | -726.10K | -729.70K | 864.00K | 871.50K | -3.70K |
| Cash Acquisitions | 196.00K | 197.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.02M | 1.02M | 373.90K | 377.10K | 391.30K |
| Cash from Investing | -550.50K | -553.20K | 852.70K | 860.10K | -2.02M |
| Total Debt Issued | 80.85M | 80.85M | 70.72M | 70.72M | 113.93M |
| Total Debt Repaid | -99.57M | -99.57M | -94.21M | -94.21M | -77.97M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.94M | -3.94M | -4.51M | -4.51M | -3.59M |
| Cash from Financing | -3.15M | -3.17M | -3.87M | -3.90M | 4.48M |
| Foreign Exchange rate Adjustments | 55.10K | 55.30K | 23.20K | 23.40K | 3.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.86M | 1.87M | -1.64M | -1.66M | 2.62M |